Skip to main content
Normal View

Vaccination Programme

Dáil Éireann Debate, Thursday - 9 December 2021

Thursday, 9 December 2021

Questions (336, 337, 339)

Charles Flanagan

Question:

336. Deputy Charles Flanagan asked the Minister for Health if the Covid-19 treatment regkirona which is approved by the European Medicines Agency will be made available to Irish patients; and if he will make a statement on the matter. [61040/21]

View answer

Charles Flanagan

Question:

337. Deputy Charles Flanagan asked the Minister for Health if his attention has been drawn by the decision by the Dutch government and eight other EU states to acquire the EMA-approved regkirona medicine for Covid-19 patients; and if he will make a statement on the matter. [61041/21]

View answer

Charles Flanagan

Question:

339. Deputy Charles Flanagan asked the Minister for Health if a detailed reply will issue in respect of correspondence (details supplied) sent to his Department. [61077/21]

View answer

Written answers

I propose to take Questions Nos. 336, 337 and 339 together.

The Health Service Executive (HSE) is responsible for purchases such as those described.

As the Deputy is aware, the procurement of services and goods within the HSE must also be carried out in compliance with relevant national and EU policy and legislation including DPER guidelines on public procurement.

Further information is available at the following link: www.hse.ie/eng/about/who/healthbusinessservices/procurement/

My Department has been in direct contact with the correspondent to let them know of the correct protocols involved.

Question No. 337 answered with Question No. 336.
Top
Share